Health Care: Drugs

Acorda Therapeutics Inc (ACOR: NASDAQ)

$33.84 -1.72 | -4.84%
02/27/15 - 04:00 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 0.00 16.44M 154.96M 30.60M
Operating Gains/Losses n.a. -182.00K -701.00K 639.00K
Extraordinary Gains / Losses n.a. 0.00 0.00 0.00
(Increase) Decrease In Receivables n.a. -4.46M -3.50M -556.00K
(Increase) Decrease in Inventories n.a. -5.12M 7.43M 10.04M
(Increase) Decrease In Other Current Assets n.a. 0.00 0.00 -372.00K
(Decrease) Increase In Payables n.a. -5.78M 11.74M -6.11M
(Decrease) Increase In Other Current Liabilities 0.00 18.00K -725.00K -1.14M
(Increase) Decrease In Other Working Capital n.a. -5.39M -12.28M -7.22M
Other Non-Cash Items n.a. 25.05M 22.08M 32.34M
Net Cash From Continuing Operations n.a. 39.28M 52.12M 66.34M
Net Cash From Discontinued Operations n.a. 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0.00 39.28M 52.12M 66.34M
Sale of Property, Plant & Equipment n.a. 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments n.a. 191.00M 264.75M 227.50M
Purchases of Property, Plant & Equipment 0.00 -7.16M -13.58M -5.79M
Acquisitions n.a. -7.50M 0.00 0.00
Purchases of Short-Term Investments n.a. -221.43M -322.46M -266.74M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0.00 -45.09M -71.28M -45.02M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock n.a. 12.79M 4.34M 3.96M
Repayment of Long-Term Debt 0.00 -909.00K -1.25M -1.96M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net n.a. 91.00K 0.00 0.00
Net Cash From Financing Activities 0.00 11.97M 3.09M 2.00M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 0.00 6.16M -16.08M 23.31M

Portfolios with ACOR

Latest ACOR Headlines from TheStreet

More Financial News for ACOR

Press Releases for ACOR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter